An article in MIT's Technology Review talks about ZS Genetics' approach to next-gen sequencing and how it could impact the field. As a "relative newcomer," says the article, ZS Genetics’ technology uses electron microscopy to image strands of DNA labeled with iodine and bromine. The company, which hopes to have a prototype this summer, is aiming for read lengths in the 1,000 base-pairs range.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The US Food and Drug Administration has approved Alnylam's RNAi-based therapy Onpattro, according to Stat News.

Harvard Medical School's Seth Cassel and Cigall Kadoch argue in a Baltimore Sun op-ed that the recent TAILORx trial shows the potential of genomic-based medicine.

Researchers in the UK are working on using gene drives to control malaria-carrying mosquitoes, the Telegraph reports.

In PLOS this week: genetic architecture mediating gene expression, metabolomic patterns in multiple myeloma, and more.